Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis Condition

Roche

Status: Completed

Conditions: Multiple Sclerosis, Relapsing-Remitting

Study type: Observational

Funder types: Industry

Identifiers

NCT02598167

ML29715

Details and patient eligibility

About

This multi-center non-interventional, observational, cross-sectional study in adult participants with relapsing remitting multiple sclerosis (RRMS) will evaluate the participants' preferences for disease modifying treatments (DMT) in routine clinical practice.

Enrollment: 223 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participants aged greater than or equal to (>/=) 18 years
• Participants who have a diagnosis of RRMS as documented in their medical records
• Participants who have been prescribed a DMT for at least 3 months
• Participants who have an expanded disability status scale (EDSS) score of 1-6 points

Exclusion criteria

• Participants with any personal or medical condition that in opinion of the investigator would interfere with or make impossible proper participation in the study

Trial design

223 participants in 1 patient group

RRMS Population

Description:

Participants with a diagnosis of RRMS and being prescribed with a DMT for a period of at least 3 months according to standard local clinical practice will be included.